Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersOperating ExpensesOperating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

RxSight (RXST) Interest & Investment Income (2020 - 2025)

Historic Interest & Investment Income for RxSight (RXST) over the last 6 years, with Q3 2025 value amounting to $2.4 million.

  • RxSight's Interest & Investment Income fell 1823.81% to $2.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $9.8 million, marking a year-over-year increase of 1681.3%. This contributed to the annual value of $9.5 million for FY2024, which is 4411.32% up from last year.
  • As of Q3 2025, RxSight's Interest & Investment Income stood at $2.4 million, which was down 1823.81% from $2.3 million recorded in Q2 2025.
  • In the past 5 years, RxSight's Interest & Investment Income ranged from a high of $2.9 million in Q3 2024 and a low of $10000.0 during Q4 2021
  • For the 5-year period, RxSight's Interest & Investment Income averaged around $1.3 million, with its median value being $1.6 million (2024).
  • Per our database at Business Quant, RxSight's Interest & Investment Income tumbled by 8979.59% in 2021 and then soared by 826000.0% in 2022.
  • RxSight's Interest & Investment Income (Quarter) stood at $10000.0 in 2021, then skyrocketed by 8260.0% to $836000.0 in 2022, then soared by 98.68% to $1.7 million in 2023, then surged by 62.97% to $2.7 million in 2024, then fell by 12.23% to $2.4 million in 2025.
  • Its last three reported values are $2.4 million in Q3 2025, $2.3 million for Q2 2025, and $2.5 million during Q1 2025.